Peters Michel L, de Meijer Claudine, Wyndaele Dirk, Noordzij Walter, Leliveld-Kors Annemarie M, van den Bosch Joan, van den Berg Pieter H, Baka Agni, Gaultney Jennifer G
Real World Strategy and Analytics, Mapi Group, Houten, The Netherlands.
Bayer B.V., Mijdrecht, The Netherlands.
Appl Health Econ Health Policy. 2018 Feb;16(1):145. doi: 10.1007/s40258-017-0364-4.
The article Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer, written by Michel L. Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G. Gaultney was originally published electronically on the publisher's internet portal (currently SpringerLink) on 2nd September, 2017 without open access.
由米歇尔·L·彼得斯、克劳丁·德·梅杰、德克·温代尔、沃尔特·诺德齐、安妮玛丽·M·莱利维尔德 - 科斯、琼·范登博施、彼得·H·范登伯格、阿格尼·巴卡、詹妮弗·G·高尔特尼撰写的《镭 - 223在转移性去势抵抗性前列腺癌中的荷兰经济价值》一文最初于2017年9月2日在出版商的互联网门户网站(当前为SpringerLink)上以电子形式发表,未开放获取。